Choosing a Tissue Bank

As a surgeon, you know that every surgical procedure involves risk. The question is how to reduce that risk to an absolute minimum. For surgeries involving tissue implants, RTI Biologics has developed methodologies to address the risk of infection that could be caused by the implants themselves. We believe the more you know about RTI, the more confident you will be in the safety of our tissue implants.

The safety of any tissue is contingent on three stages – donor screening, laboratory testing and tissue preparation validated to address potential disease transmission. Tissue banks share strict donor medical, behavioral and physical criteria provided by the Food and Drug Administration (FDA) and the American Association of Tissue Banks (AATB). Furthermore, tissue banks may implement additional criteria based on their individual implant portfolio, processing methods and/or tissue availability.

Some companies rely on donor screening, laboratory testing and aseptic processing for the safety of their implants. Although the risk of disease transmission through allograft transplantation is low due to screening and testing methods, RTI’s proprietary, validated sterilization processes reduce this risk even further. Wherever possible, RTI has advanced beyond the use of aseptic processing, which does not ensure the removal or inactivation of microorganisms inherent to the donor or tissue, to better protect recipients from the risk of donor-to-recipient disease transmission.

More than two million implants distributed with zero incidence of allograft-associated infection – at RTI Biologics, that’s our track record, and we’re proud of it. You need a tissue provider you can trust. At RTI, we give you more than a million reasons to trust us.

See if your tissue provider meets the high standards of RTI Biologics. Download the Critical Factors in Allograft Safety checklist to compare.